Sanofi announced price cuts that cap the cost of insulin at $35 for patients back in March. The reduced cost took effect on New Year's Day.

Eli Lilly announced Wednesday a series of price cuts that would lower the price of the most commonly used forms of its insulin 70% and said it will automatically cap out-of-pocket insulin costs at ...

Drugmaker Eli Lilly says it will cut its insulin prices up to 70% and cap out-of-pocket costs for privately insured consumers at $35 a month.

Eli Lilly & Co.’s announcement that it is slashing prices for its major insulin products could make life easier for some diabetes patients while easing pressure on Big Pharma. It also casts ...

The top 3 insulin makers recently announced price cuts. Here’s what to know Eli Lilly, Novo Nordisk and Sanofi all announced plans to cap prices on the diabetes treatment after pressure from ...

A law that coaxed companies to lower the price of drugs came with a little-known consequence: smaller discounts for low-income health clinics.

The Inflation Reduction Act works to bring down skyrocketing drug prices. Here's how it will—and won't—help insulin prices.

Eli Lilly cuts price of insulin, capping drug at $35 per month The moves announced Wednesday promise critical relief to some people with diabetes who can face annual costs of more than $1,000 for ...

Here’s why slashing insulin prices will actually save Big Pharma money The cuts will kick in just as a federal cap on Medicaid payments is eliminated.

Eli Lilly plans to cut prices on its most commonly prescribed insulin products by 70% and will also cap customers' out-of-pocket costs at $35 a month for those with commercial insurance who use ...